Developing science,
delivering therapies

4d

Our company

We are pioneers in harnessing bacteria as a revolutionary new class of medicines – called live biotherapeutics.

Our approach
developing-science

Developing science

From asthma to cancer, we conduct world-leading research to identify live biotherapeutics with drug-like functionality to treat a range of diseases.

What we do
delivering-therapies

Delivering therapies

We are uniquely positioned to rapidly translate our research into regulated, safe and efficacious therapies for patients.

Find out more

News

4D pharma plc announces first patient enrolment in Blautix IBS Phase II study
4D pharma plc (AIM: DDDD), announces positive top-line results for its Phase 1b study of Thetanix in paediatric patients with Crohn’s disease.
Data suggests that MRx0004 is a promising next-generation therapeutic for management of asthma

BACK TO TOP